12th Nov 2009 07:00
12 November 2009
HENDERSON MORLEY PLC
("Henderson Morley" or the "Company")
(AIM: HML)
APPOINTMENT
The Board of Henderson Morley plc, the Aim quoted biotechnology company, is pleased to announce the appointment of Professor Anant Sharma to the Company's Scientific Advisory Board. Professor Sharma is a consultant ophthalmic surgeon at the Moorfields Eye Hospital (Bedford), and is Visiting Professor at Cranfield University.
With over 40 publications, predominantly in the field of corneal surgery and disease, Professor Sharma is a member of the Royal College of Ophthalmologists Research and Development Working Party and has been involved with a number of clinical development projects for many aspects of ocular disease.
It is anticipated that Professor Sharma will play an active role in the continued development of the ophthalmic indications of ICVT and act as an advisor to the Company on aspects of ophthalmic clinical trials and product development.
Commenting, Henderson Morley's Chairman Andrew Knight said "I am very pleased to welcome Professor Sharma as a member of the Scientific Advisory Board, his knowledge and experience has already proven to be very valuable to our planned continued development of the ICVT ophthalmic product."
-- END--
Enquires
HENDERSON MORLEY PLC 0121 442 4600 Andrew Knight, Chairman
BISHOPSGATECOMMUNICATIONS LTD 0207 562 3350Maxine Barnes Gemma O'Hara
BREWIN DOLPHIN INVESTMENT BANKING 0113 241 0126Neil Baldwin
RIVINGTON STREET CORPORATE FINANCE 0207 562 3380Monisha Varadan
-- End --
Related Shares:
HML.L